Table 2.
Comparison of COVID hospital activity in the 2-month study period with the same period in 2019
| April–May 2020 | April–May 2019 | |
|---|---|---|
| Admissions | ||
| Emergency admissions | 91 | 107 |
| Elective admissions | 10 | 87 |
| Total admissions | 101 | 194 |
| Bed days | 271 | 881 |
| Outpatient workload | ||
| Outpatient referrals | 481 | 928 |
| Outpatient clinic* | 972 | 895 |
| Early prostate cancer nurse* | 198 | 224 |
| Cancer coordinator* | 195 | 294 |
| Outpatient procedures | ||
| Flexible cystoscopy | 156 | 343 |
| Prostate biopsy | 9 | 38 |
| ESWL** | 66 | 113 |
| Urodynamics | 0 | 73 |
| Nurse-led procedure clinic | 181 | 383 |
| New cancer diagnoses | 16 | 47 |
| Bladder cancer | 5 | 5 |
| Renal cancer | 4 | 10 |
| Testicular cancer—primary | 2 | 1 |
| Testicular cancer—RPLND | 0 | 1 |
| Prostate cancer | 4 | 26 |
| Ureteric TCC | 1 | 3 |
| Penile cancer | 0 | 1 |
*Majority of consultations were conducted by phone in the COVID-19 period and in person in the 2019 period
**ESWL included ‘hot ESWL’ for ureteric stones in 2020 but no ‘hot ESWL’ performed in 2019
Bed days, summative number of days during which a bed was occupied by a urology patient; TRUS transrectal ultrasound-guided, ESWL extracorporeal shock wave lithotripsy, RPLND retroperitoneal lymph node dissection, TCC transitional cell carcinoma